| Hepatitis Panel A B C Acute Blood Test |
This panel contains the following tests: Hepatitis B surface antigen (HBsAg) . This is the first test to show a positive result with acute hepatitis B infection. The level of the antigen rises before symptoms begin and then returns to normal
| Chronic Hepatitis B and C: Basic Science to Clinical Applications |
The scope of the book is very broad, covering a wide range of areas in HBV/HDV and HCV research, including both basic and clinical science. The selected topics range from epidemiology, immunology, molecular virology and oncology, to clinical therapy. Chronic Hepatitis B and C consists of 13 chapters, each being a review of a special topic on HBV or HCV. While review articles on a special topic can be found in periodical journals, they tend to be more restricted in presentation. Therefore, this book will provide more in-depth coverage of what are presented as "unpublished results" and "data not shown" in journal articles. Furthermore, several authors in this book do not write review articles regularly. Some authors wrote reviews on a specific topic regularly, but they tried a new topic in this book (e.g, Dr. YF Liaw on "natural course," Dr. Shih on "virion release," Dr. Michael Lai on "lymphotropism of HCV," etc.) . Overall, the book will offer useful information at the cutting age.
| Chronic Viral Hepatitis: Diagnosis and Therapeutics |
Chronic viral hepatitis affect hundreds of millions of people worldwide, and each year millions more people become infected. In Chronic Viral Hepatitis, Second Edition, a panel of distinguished clinicians and clinical investigators build upon the first edition by comprehensively reviewing all the relevant new information regarding resistance, side effects, and therapies for chronic viral hepatitis. The text covers recent advances in the understanding of pathogenesis of viral hepatitis while discussing promising agents in development for its treatment. The authors devote special attention to reactivation of hepatitis B with chemotherapy and immunosuppression, herbal and non-traditional therapies, chronic viral hepatitis in the pediatric population, and immunology and immunotherapy of HCV and provide relative costs for all diagnostic and therapeutic options. Authoritative and up-to-date, Chronic Viral Hepatitis, Second Edition offers today's gastroenterologists, internists, hepatologists, and infectious disease specialists a practical guide to the recognition, diagnosis and treatment of chronic viral hepatitis from a multidisciplinary approach.
| Hepatitis C Virus HCV Quantitative Real time PCR Blood Test |
This test is used to determine the number of international units (IU) of the hepatitis C virus RNA per milliliter of serum or plasma in known HCV-positive patients. Hepatitis C is an infectious disease affecting the liver, caused by the
| Viral Hepatitis in Children: Unique Features and Opportunities |
Viral Hepatitis in Children: Unique Features and Opportunities is a unique volume that has been created to address the special considerations regarding viral hepatitis in children. It includes the latest information and recommendations specifically directed at the pediatric population, and highlights the knowledge gaps which will need to be filled to improve our understanding of these infections and treatment of this special group. Experienced practitioners from around the world have contributed these reviews, incorporating the latest studies, the current recommendations, and the distinctive pediatric issues that shape clinical care. This material will determine the research agenda for this field going forward. Viral Hepatitis in Children: Unique Features and Opportunities is a valuable resource for pediatricians, pediatric gastroenterologists, hepatologists and infectious disease specialists that care for children with viral hepatitis. Content Level Professional/practitioner
| Hepatitis Viruses and Hepatocellular Carcinoma |
The role of hepatitis B and C in causing hepatocellular carcinoma has been made clear in the last 2030 years by clinical, basic, and epidemiological studies. Recent research has also explored the prevention of hepatocellular carcinoma through the control of chronic hepatitis B or C viral infection. This review volume covers in detail the various aspects of hepatitis viruses in relation to hepatocellular carcinoma, ranging from the epidemiology of the disease to its prevention and treatment. Readers will thus gain a complete, well-informed knowledge of this increasingly prevalent disease.
| Autoimmune Hepatitis: A Guide for Practicing Clinicians |
With a focus on practical patient related issues, Autoimmune Hepatitis: A Guide for Practicing Clinicians serves as a useful practical, and much needed, resource for all those physicians presented with managing patients diagnosed with autoimmune hepatitis, both acutely and over the long term. It provides a basis for clinicians to understand the etiology of the disease, as well as special circumstances where management dilemmas often arise. Emphasis is given to providing management advice of immediate use to clinicians, something not presently offered by other larger general texts. The chapters are written by those with an expertise and training in this field and include the most up to date information. The book will be of great value to Gastroenterologists, Hepatologists, and Internists at all levels who see patients presenting with autoimmune hepatitis.
| Hepatitis C Virus Antibody Blood Test |
books > computers & technology > programming > software design testing & engineering > testing
Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV) . The infection is often asymptomatic, but once established, it can progress to chronic scarring of the liver (fibrosis and cirrhosis) . In some cases, those
| Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future |
Chronic Hepatitis C Virus: Lessons from the Past, Promise for the Future" documents the monumental advances that have been made in our understanding of chronic HCV during the past decade. The first section reviews the natural history of chronic HCV, how this virus can affect other organs in addition to the liver, and whether treating chronic HCV alters the natural history of this disease. Section 2 reviews the advances that have been made in the treatment of chronic HCV during the past decade with interferon based therapy. Separate chapters on response guided therapy and how to manage the adverse events associated with these medications provide the physician with the concepts required to more effectively treat chronic HCV now and in the future. As the genetics of virologic response have recently been elucidated, a chapter is devoted to helping the clinician understand how genes that modulate disease processes and their treatment are identified and utilized in clinical care. Section 3 deals with the future of HCV treatment and specific inhibitors of HCV. Specific chapters explain how targets for drugs are identified and how drugs are then developed and tested; how mutations of HCV develop and how anti-viral agents will affect this process; the most up to date data regarding the treatment of chronic HCV with peginterferon, ribavirin and anti-viral agents; and the potential to treat chronic HCV with just oral anti-viral agents and without peginterferon and ribavirin in the future. The final section of this book covers issues related to liver transplantation in patients with chronic HCV. Separate chapters review the natural history of chronic HCV in liver transplant recipients and the impact of utilizing HCV positive donors. The volume concludes with chapters that cover the treatment of chronic HCV both prior to and after liver transplantation with potent anti-viral agents. "Chronic Hepatitis C Virus: Lessons from the Past, Promise for the Future" is a valuable resourc
| Hepatitis C Virus Disease: Immunobiology and Clinical Applications |
books > health fitness & dieting > diseases & physical ailments
Despite numerous hepatitis C virus infection studies, its pathogenesis and medical treatment have not been fully explained. This comprehensive volume, written by experts in the field, covers the most recent advances in the study of HCV, moving from basic research to clinical applications. The first chapters of this volume analyze the full spectrum of immune responses to HCV. The volume also includes contributions that explain the state of the art in IFN-alpha treatment of HCV patients.